Trials / Completed
CompletedNCT05019378
SVF Therapy for Human Knee Osteoarthritis
Evaluation of the Autologous Stromal Vascular Fraction Therapy for Knee Osteoarthritis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Zhongnan Hospital · Academic / Other
- Sex
- All
- Age
- 50 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to asses the safety and efficacy of SVF for treatment of knee osteoarthritis, and establish a novel method to provide 3D MRI imaging for human knee cartilage to qualitatively and quantitatively evaluate cartilage regeneration.
Detailed description
Study participants voluntarily provided written informed consent to participate in the study. The two knees of each patient were randomly assigned to autologous SVF treatment group or non-treatment control group. The patients were evaluated every 4 weeks for safety and efficacy of autologous SVF therapy for 24 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | SVF treatment | autologous SVF (10E8 cells) |
Timeline
- Start date
- 2016-12-19
- Primary completion
- 2018-08-23
- Completion
- 2019-01-28
- First posted
- 2021-08-24
- Last updated
- 2021-08-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05019378. Inclusion in this directory is not an endorsement.